The forecasted values for the sold production of medicaments containing penicillins or derivatives thereof in Italy for 2024 to 2028 show a gradual decline from 22.484 million euros in 2024 to 18.434 million euros in 2028. This consistent decrease represents a year-on-year decline: -4.57% from 2024 to 2025, -4.76% from 2025 to 2026, -4.93% from 2026 to 2027, and -5.14% from 2027 to 2028. The compound annual growth rate (CAGR) over this five-year period is approximately -4.85%. In 2023, the production stood at 23.5 million euros, illustrating a clear downward trend.

Future trends to watch for include:

Advancements in alternative antibiotics which might impact penicillin demand.
Regulatory changes affecting production and sale of antibiotic medications.
Market shifts towards more personalized medicine approaches.
Potential impacts from global health issues influencing local pharmaceutical production.